Market Place
Sourcing Support
Important Update on Listing Status and Strategic Direction
03 Jan 2024 //
GLOBENEWSWIRE
Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision
13 Dec 2023 //
GLOBENEWSWIRE
Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility
21 Nov 2023 //
GLOBENEWSWIRE
Nemaura Launches Direct to Consumer Offering of Metabolic Health Program
14 Nov 2023 //
GLOBENEWSWIRE
Nemaura Medical Reports Fiscal Second Quarter 2024 Results
13 Nov 2023 //
GLOBENEWSWIRE
Nemaura Medical Announces Appointment of Mr Nikolai Rozanov as Strategic Adviser
26 Sep 2023 //
GLOBENEWSWIRE
Nemaura Medical to Present at the Maxim Group Emerging Growth in A.I. Conference
18 Sep 2023 //
GLOBENEWSWIRE
Nemaura Medical Provides Update on Nasdaq Compliance Status and Process
14 Sep 2023 //
GLOBENEWSWIRE
Nemaura Medical Announces Participation at HLTH 2023, Las Vegas
12 Sep 2023 //
GLOBENEWSWIRE
Nemaura Medical Reports Interim Results
11 Sep 2023 //
GLOBENEWSWIRE
Nemaura Medical Announces SFDA Approval of sugarBEAT®
17 Aug 2023 //
GLOBENEWSWIRE
Nemaura Reports Fiscal First Quarter 2024 Results and Provides Business Update
14 Aug 2023 //
GLOBENEWSWIRE
Nemaura Medical Secures $6.5m in Non-Dilutive Funding
11 Aug 2023 //
GLOBENEWSWIRE
Nemaura Medical Reports Financial Results and Provides Business Update
14 Jul 2023 //
GLOBENEWSWIRE
Nemaura Medical Scales-Up Pilot Expansion of proBEAT 56 Corporations
27 Jun 2023 //
GLOBENEWSWIRE
Nemaura Medical to Participate at the Collision Conference in June 26-29, 2023
22 Jun 2023 //
GLOBENEWSWIRE
Nemaura Medical to Exhibit & Provide Live Product of Its Non-invasive Glucose
15 Jun 2023 //
GLOBENEWSWIRE
Nemaura Medical to Participate in Fireside Chat Hosted by EF Hutton
21 Mar 2023 //
GLOBENEWSWIRE
Nemaura Includes Insulin on List of Drugs Eligible for DuoPack License Agreement
15 Mar 2023 //
GLOBENEWSWIRE
Nemaura Medical Announces Receipt of Notice from Nasdaq
09 Mar 2023 //
GLOBENEWSWIRE
Nemaura Reports Fiscal Third Quarter 2023 Results and Provides Business Update
24 Feb 2023 //
GLOBENEWSWIRE
Nemaura Medical Announces Closing of Approximately $8.4M Direct Offering
31 Jan 2023 //
GLOBENEWSWIRE
Nemaura Announces Pricing of Approximately $8.4M Registered Direct Offering
27 Jan 2023 //
GLOBENEWSWIRE
Nemaura Receives First Purchase Order from U.S. Health Provider HealthFleet
26 Jan 2023 //
GLOBENEWSWIRE
Nemaura Medical Reports Initial Patient Data from UK NHS Miboko Study
24 Jan 2023 //
GLOBENEWSWIRE
Nemaura Medical to Present at the Sidoti & Co. Micro Cap Virtual Conference
11 Jan 2023 //
GLOBENEWSWIRE
Nemaura Medical to Present at the Planet MIcroCap Showcase: Virtual 2022
01 Dec 2022 //
GLOBENEWSWIRE
Nemaura Commences Pilot Program of Miboko with the NHS in the United Kingdom
29 Nov 2022 //
GLOBENEWSWIRE
Nemaura Medical Reports Fiscal Second Quarter 2023 Results
15 Nov 2022 //
GLOBENEWSWIRE
Nemaura Medical to Present at the Bernstein 2ND Annual CGM Disruptors Conference
11 Nov 2022 //
GLOBENEWSWIRE
Nemaura Receives Provisional Purchase Order from Middle East Licensee TPMENA
12 Oct 2022 //
GLOBENEWSWIRE
Nemaura Medical to Present at the MicroCap Rodeo Windy City Roundup 2022
04 Oct 2022 //
GLOBENEWSWIRE
Nemaura Medical Reports Fiscal First Quarter 2023 Results
15 Aug 2022 //
GLOBENEWSWIRE
Nemaura Medical Granted UK Trademark “Meta Score,” a Digital Biomarker
21 Jul 2022 //
GLOBENEWSWIRE
Nemaura Medical Reports Financial Results and Provides Business Update
30 Jun 2022 //
GLOBENEWSWIRE
Nemaura Medical Strengthens Balance Sheet with Further Non-Dilutive Funding
23 May 2022 //
GLOBENEWSWIRE
Nemaura Medical to Present at the H.C. Wainwright Conference
19 May 2022 //
GLOBENEWSWIRE
Nemaura Medical to Present at the Maxim Group 2022 Virtual Growth Conference
24 Mar 2022 //
GLOBENEWSWIRE
Nemaura Medical Announces Q3 FY 2022 Financial Results; Provides Business Update
14 Feb 2022 //
GLOBENEWSWIRE
Nemaura Medical to Present at Diabetes Technology Society 2021
03 Nov 2021 //
GLOBENEWSWIRE
Nemaura Medical Announces Commercial Agreement with UK Licensee
27 Sep 2021 //
GLOBENEWSWIRE
Nemaura Medical Offers Sought-After Solutions in Areas of Unmet Medical Need
22 Sep 2021 //
GLOBENEWSWIRE
Nemaura Medical announce Professor Osama Hamdy Joins their Advisory Board
17 Sep 2021 //
GLOBENEWSWIRE
Nemaura Medical Reports Financial Results and Provides Business Update
16 Aug 2021 //
GLOBENEWSWIRE
Nemaura Medical to Present at the Access to Giving Virtual Investor Conference
12 Jul 2021 //
GLOBENEWSWIRE
Nemaura Medical Reports Results and Provides Business Update
30 Jun 2021 //
GLOBENEWSWIRE
Nemaura Announces Presentation on its Licensed Why WAIT Program During the ADA
30 Jun 2021 //
GLOBENEWSWIRE
Nemaura Medical Licenses Validated Mobile Application Create Powerful Diabetes
21 Sep 2020 //
BIOSPACE
Nemaura Announces Proposed Underwritten Public Offering
27 Jul 2020 //
BUSINESSWIRE
Nemaura Enters into Letter of Intent to Acquire Healthimation Augment proBEAT™
27 Jul 2020 //
BUSINESSWIRE
